We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eurand N.V. (MM) | NASDAQ:EURX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.985 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
The conference call schedule is as follows:
Hot Features
Premium
7:00 a.m. ET: Release of third quarter 2010 financial results
8:20 a.m. ET: Dial in to participate in the conference call:
-- U.S. Participants dial 1-877-407-9039
-- International Participants dial +1-201-689-8470
8:30 a.m. ET: Conference call begins
Call Replay: A replay of the call will be available from 11:30 a.m. ET on
November 5, 2010 through December 5, 2010. The Conference ID
Number is 358370.
-- U.S. Participants dial +1-877-870-5176
-- International Participants dial +1-858-384-5517
Webcast: A live webcast of the call also will be available from the Investor Relations section of the corporate web site at www.eurand.com. Following the live webcast, the archived version of the call will be available at the same URL until December 5, 2010.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.
Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email Contact
1 Year Eurand N.V. (MM) Chart |
1 Month Eurand N.V. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
